Acadia Pharmaceuticals Inc. (ACAD) Earnings
NASDAQ·Healthcare·Biotechnology
$20.19
+2.25%
Mkt Cap $3.40B
EPS — Estimate vs Actual
Mkt Cap
$3.40B
P/E
9.17
Fwd P/E
31.64
P/S
3.10
Rev TTM
—
EPS TTM
$2.20
NASDAQ·Healthcare·Biotechnology
$20.19
+2.25%
Mkt Cap $3.40B
Mkt Cap
$3.40B
P/E
9.17
Fwd P/E
31.64
P/S
3.10
Rev TTM
—
EPS TTM
$2.20